Rivian’s $5 Billion Georgia EV Megaplant: A Bold Gamble to Outdrive Tesla, Ford & More

Rivian’s Stock Rockets: $5B EV Factory and Analyst Upgrades Spark a Rally

  • Stock Price & Cap: ~$15.2 per share (Sept 29, 2025), Market Cap ~$18.5B [1] [2]. 52-week range: $9.50 – $17.15 [3].
  • Recent Performance: Up sharply in mid-Sept (e.g. +5.98% on Sept 26 [4]) but dipped ~2.6% on Sept 29. 1-year return ~+35%. Analysts note trading volatility around key news.
  • Q2 2025 Results: Revenue $1.303B (+12.5% Y/Y) [5]; net loss ~$1.1B (EPS -$0.97) [6]. Automotive gross margin remains negative. Production 5,979 vehicles; deliveries 10,661 in Q2 [7]. Strong cash cushion (~$7.5B end-Q2 after VW’s $1B investment) [8]. Company confirmed 2025 guidance of 40–46K vehicles and the R2 SUV launch (~$45K base) on schedule [9] [10].
  • Key Developments: Rivian broke ground on a $5B Georgia plant (2028 start; 400K capacity; 7,500 jobs by 2030) [11] [12]. Volkswagen added a $1B investment (June 2025) to fund a joint EV venture [13]. Rivian opened “Adventure Network” chargers for all EVs (first at Joshua Tree) and partnered on Illinois solar (agrivoltaics) to power its charging network [14] [15]. It is already building “hundreds” of pre-production R2 SUVs ahead of full launch in early 2026 [16]. On the other hand, Rivian faces setbacks: it recalled ~24K R1 pickup/SUVs for a software defect and is under NHTSA probe for ~17K delivery vans (seat-belt issue) [17].
  • EV Market & Competition: The U.S. EV market is cooling: EVs were ~7.4% of Q2 2025 auto sales [18], with Tesla still ~46% of EV volume [19]. Legacy OEMs (GM, Ford, Honda, VW) are expanding EVs too. Rivian competes with Tesla (Cybertruck), Ford (Lightning/F-150 EV), GM (Hummer EV) and others in trucks/SUVs, and by 2026 with mid-market R2 vs. Lucid, Nissan, etc. The pending end of U.S. EV tax credits (Sept 30, 2025) and looser fuel-economy penalties add headwinds [20] [21]. Rising tariffs (on batteries, etc.) will raise Rivian’s costs by “a couple thousand dollars” per vehicle [22]. Overall, investors watch whether Rivian can scale production fast enough amid these challenges.
  • Analyst Sentiment: Street consensus is neutral-to-cautious. The average 1-year price target is only ~$14 [23] (below today’s price). Goldman Sachs (analyst Mark Delaney) kept a Neutral rating but raised its target to $15 [24]. Mizuho (Vijay Rakesh) also stayed Neutral and nudged its target to $14 [25]. Overall, about 5 Buys, 16 Holds and 3 Sells (avg. “Hold”) [26]. Goldman’s and Cantor Fitzgerald’s latest notes highlight expected strong Q3 deliveries (Cantor forecasts ~15,675 cars, above consensus [27]). Some experts remain skeptical: CNBC’s Jim Cramer recently warned investors to “avoid buying Rivian now,” criticizing the high spending on the Georgia plant [28]. By contrast, other analysts see promise: one Nasdaq writer notes that Volkswagen’s investment “signals outside confidence in Rivian’s technology platform and future vehicle plans” [29]. GuruFocus’s model even pegs a one-year “fair value” of $20.86 (about 34% above current levels) [30], reflecting highly divergent views.
  • Forecasts (Short & Long Term): Near-term price forecasts vary. Some models see modest upside: for example, a short-term forecast suggests RIVN could reach the $16–17 range by early October (≈10% gain) before pulling back [31]. By year-end 2025, consensus targets are around $13–15, implying limited upside. StockAnalysis.com projects revenue growing from $5.40B in 2025 to $7.08B in 2026 (+31%) [32] [33], with EPS losses narrowing from -$2.71 to -$2.54 [34]. Longer term, Rivian must deliver on R2/R3 to drive profits. A bearish scenario (AI-driven) sees RIVN drifting to the low-$12s by late 2026 [35], while a bullish (GuruFocus) view sees mid-$20s in a few years. In short, most analysts expect only mild growth: the average 2026 target is in the mid-$12s [36]. Key catalysts that could lift the stock include beating delivery targets or launching new models profitably; conversely, missed guidance or deeper losses could push RIVN toward the low-$10s.

Sources: Latest stock data from investing and marketcap trackers [37] [38]; Rivian financials from Q2’25 report and analyst write-ups [39] [40]; news from Rivian releases and news outlets [41] [42] [43]; expert commentary from analyst reports and media [44] [45] [46]. All figures and quotes cited as shown.

Rivian vs Lucid: Which EV Stock Will Skyrocket First?

References

1. www.investing.com, 2. www.marketbeat.com, 3. www.marketbeat.com, 4. www.investing.com, 5. www.nasdaq.com, 6. www.nasdaq.com, 7. www.nasdaq.com, 8. www.nasdaq.com, 9. www.automotivedive.com, 10. www.automotivedive.com, 11. techcrunch.com, 12. www.alphaspread.com, 13. www.nasdaq.com, 14. www.repairerdrivennews.com, 15. eletric-vehicles.com, 16. eletric-vehicles.com, 17. www.investing.com, 18. caredge.com, 19. caredge.com, 20. www.automotivedive.com, 21. www.cbtnews.com, 22. www.automotivedive.com, 23. stockanalysis.com, 24. www.gurufocus.com, 25. www.gurufocus.com, 26. www.marketbeat.com, 27. www.investing.com, 28. eletric-vehicles.com, 29. www.nasdaq.com, 30. www.gurufocus.com, 31. coincodex.com, 32. stockanalysis.com, 33. stockanalysis.com, 34. stockanalysis.com, 35. coincodex.com, 36. coincodex.com, 37. www.investing.com, 38. companiesmarketcap.com, 39. www.nasdaq.com, 40. www.automotivedive.com, 41. techcrunch.com, 42. www.alphaspread.com, 43. eletric-vehicles.com, 44. www.gurufocus.com, 45. www.investing.com, 46. www.nasdaq.com

IBM Stock Soars on Quantum Breakthrough and AI Revival – Key Updates (Sept 25, 2025)
Previous Story

IBM’s 2025 Surge: AI Boom, Quantum Breakthrough & Stock Soars to New Heights

Maison Solutions (MSS) Stock Explodes on Crypto Pivot – Full Earnings & Forecast Report
Next Story

Maison Solutions (MSS) Stock Explodes on Crypto Pivot – Full Earnings & Forecast Report

Stock Market Today

  • FSZ.DB.C:CA Debentures - AI-Generated Signals and Trading Plans for Fiera Capital 7.75% Senior Subordinated Notes
    October 19, 2025, 10:46 PM EDT. On October 19, 2025, AI-generated signals for Fiera Capital Corporation 7.75% senior subordinated unsecured debentures (FSZ.DB.C:CA) outline concrete trading plans. The Long setup suggests buying near 104.44 with a target of 105.45 and a stop at 103.92. The Short setup proposes selling near 105.45 with a target around 104.44 and a stop at 105.98. The accompanying ratings are neutral across Near, Mid, and Long terms. Note that AI-generated signals are one input among risk controls, and a timestamp check is advised. A chart is provided for FSZ.DB.C:CA to help gauge price action and risk management.
  • Midwest IPO Allotment: How to Check Share Allotment on NSE & BSE
    October 19, 2025, 10:12 PM EDT. Midwest's IPO has closed bidding, and investors are eager to view allotment details on the NSE and BSE. Current market chatter places a grey market premium (GMP) of about ₹110-₹145 per share. The issue price band is ₹1014-₹1065, and at the upper band, listing could bring gains of around ₹1,210 per share on the NSE, a roughly 13.1% upside. To check allotment, visit the official NSE or BSE portals or your broker's platform and search for 'Midwest IPO allotment' using your application number, reference number, or PAN. Allotment status is typically updated a day or two after the bid closes, and refunds (if any) and listing details follow thereafter.
  • L3Harris Secures $2.26B AEW&C Contract to Supply Global 6500 Aircraft to South Korea
    October 19, 2025, 10:06 PM EDT. L3Harris Technologies (LHX) has secured a multi-billion-dollar contract to supply modified Bombardier Global 6500 airborne early warning and control (AEW&C) aircraft to the Republic of Korea Air Force. The deal, valued at more than $2.26 billion, is a milestone for cross-border defense collaboration with Bombardier, Israel Aerospace Industries' ELTA Systems, and Korean Air. The aircraft are built for faster speeds, longer endurance, and higher altitude operations, and come with robust radar and an integrated communications suite to ensure interoperability with the U.S., NATO, and coalition forces. The program emphasizes strong local industry involvement, with Korean firms leading operations and maintenance, boosting defense autonomy. The arrangement provides near-term revenue visibility for LHX and supports growth in advanced airborne systems.
  • J.L. Bainbridge Exits Most of Biogen Stake as Biotech Eyes Turnaround
    October 19, 2025, 10:04 PM EDT. Florida-based wealth adviser J. L. Bainbridge & Co. disclosed in its Q3 SEC filing that it sold 119,376 shares of Biogen (BIIB) for an estimated $16.1 million. The position now totals only 2,969 shares worth $415,898 as of September 30, reducing Biogen's stake to 0.03% of AUM from roughly 1.4%. Top holdings after the filing include MSFT, AAPL, GOOGL, GS and ETN, signaling a broader reshuffle away from Biogen. At Friday's close, Biogen traded near $143, down about 23% over the past year. The move underscores Bainbridge's shift away from biotech exposure even as Biogen posted a strong Q2 with 7% revenue growth to $2.6 billion and raised full-year guidance.
  • Hong Kong Stocks Eye Monday Traction as Global Trade Optimism Lifts Markets
    October 19, 2025, 10:02 PM EDT. Hong Kong's Hang Seng slipped for a second straight session, ending at 23,345.05, down 108.15 points (-0.46%), hovering just below the 23,350 support and hinting at Monday traction. With European and U.S. equities higher, expectations for a broader risk-on mood kept Asian bourses in play. Friday's trade saw financials, property and tech soft, while CSPC Pharmaceutical (+3.15%), Li Auto (+1.71%), and Xiaomi (+1.69%) rose, and Alibaba (-4.27%), New World Development (-3.47%), and Meituan (-2.95%) fell. Dow (+331.94), Nasdaq (+98.80) and S&P 500 (+41.45) closed higher, fueling weekly gains of Nasdaq +7.2%, S&P 500 +5.3%, and Dow +3.4%. Oil firmed as WTI rose to $62.49 (+1.4%), up 2.4% on the week.
Go toTop